All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as
of the end of the calendar quarter for which the report is filed, and the total market value. The market value
column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in
accounts.
Filing 2022 Q2 - Restatement compared to 2022 Q1 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Sherman G. Souther
Authorized Signatory
Palo Alto, California
5/15/2023
Note: VR Adviser, LLC is filing this Form 13F on behalf of itself and the general partner entities of the investment funds for which it serves as the investment adviser, VHCP Management II, LLC, VHCP Management III, LLC and VHCP Management EG, LLC. Note: This amendment is being filed solely to remove holdings of securities of DBV Technologies S A ("DBV") from the reporting manager's holdings of 13(f) securities as of June 30, 2022. The reporting manager's holdings of DBV equity securities as of June 30, 2022 consisted of ordinary shares, which are not considered "Section 13(f) securities" and are, therefore, not reportable on Form 13F, in contrast to American depositary shares, which are reportable on Form 13F. This amendment does not reflect the disposition of any securities of DBV by the reporting manager, but merely reflects the fact that the holdings as of June 30, 2022 were in the form of ordinary shares. As of June 30, 2022, the reporting manager's holdings included 9,300,000 ordinary shares of DBV.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.